Literature DB >> 1081865

Discoid lupus erythematosus as part of a larger disease spectrum. Correlation of clinical features with laboratory findings in lupus erythematosus.

S D Prystowsky, J N Gilliam.   

Abstract

This study compares the immunologic features of a homogeneous group of patients with discoid lupus erythematosus (DLE) strictly limited to the skin (group 1) with those of patients with active discoid skin lesions plus visceral involvement (group 2) and with those of lupus erythematosus (LE) patients with proliferative glomerulonephritis (group 3). Positive antinuclear antibody (ANA) was found in 4% of group 1, 93% of group 2, and 100% of group 3. Low total hemolytic complement (CH50) was found in 4% of group 1, 47% of group 2, and 100% of group 3. Antibodies to native DNA (nDNA) were not found in group 1, were rarely found in group 2, and were present in nearly all patients in group 3. No group 1 patient had subepidermal immunoglobulin deposits in normal skin, 20% of group 2 had this finding, and 100% of group 3 had this finding. The ability to develop chronic discoid skin lesions appears to be associated with a reduced incidence of immunologic parameters of disease activity. The data suggest that patients with active discoid skin lesions rarely have severe renal disease.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1081865

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  14 in total

1.  Lupus: an overview of the disease and management options.

Authors:  William Maidhof; Olga Hilas
Journal:  P T       Date:  2012-04

2.  Association of discoid lupus erythematosus with other clinical manifestations among patients with systemic lupus erythematosus.

Authors:  Joseph F Merola; Stephen D Prystowsky; Christina Iversen; Jose A Gomez-Puerta; Tabatha Norton; Peter Tsao; Elena Massarotti; Peter Schur; Bonnie Bermas; Karen H Costenbader
Journal:  J Am Acad Dermatol       Date:  2013-03-28       Impact factor: 11.527

3.  Lupus serum IgG induces skin inflammation through the TNFR1 signaling pathway.

Authors:  Guo-Min Deng; Lena Liu; Vasileios C Kyttaris; George C Tsokos
Journal:  J Immunol       Date:  2010-05-14       Impact factor: 5.422

4.  Anti-DNA antibodies in discoid lupus erythematosus. Follow-up study.

Authors:  B Bresnihan; G R Hughes
Journal:  Ann Rheum Dis       Date:  1977-10       Impact factor: 19.103

5.  A multicentre, cross-sectional study on quality of life in patients with cutaneous lupus erythematosus.

Authors:  R Vasquez; D Wang; Q P Tran; B Adams-Huet; M-M Chren; M I Costner; J B Cohen; V P Werth; B F Chong
Journal:  Br J Dermatol       Date:  2012-09-13       Impact factor: 9.302

6.  Association of discoid lupus erythematosus with clinical manifestations and damage accrual in a multiethnic lupus cohort.

Authors:  Yesenia Santiago-Casas; Luis M Vilá; Gerald McGwin; Ryan S Cantor; Michelle Petri; Rosalind Ramsey-Goldman; John D Reveille; Robert P Kimberly; Graciela S Alarcón; Elizabeth E Brown
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-05       Impact factor: 4.794

7.  Racial Disparities in the Incidence of Primary Chronic Cutaneous Lupus Erythematosus in the Southeastern US: The Georgia Lupus Registry.

Authors:  Cristina Drenkard; Sareeta Parker; Laura D Aspey; Caroline Gordon; Charles G Helmick; Gaobin Bao; S Sam Lim
Journal:  Arthritis Care Res (Hoboken)       Date:  2019-01       Impact factor: 4.794

8.  Human histocompatibility antigen associations in subacute cutaneous lupus erythematosus.

Authors:  R D Sontheimer; P Stastny; J N Gilliam
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

9.  Clq deposits at the dermoepidermal junction: a marker discriminating for discoid and systemic lupus erythematosus.

Authors:  M Leibowitch; D Droz; L H Noël; M F Avril; J Leibowitch
Journal:  J Clin Immunol       Date:  1981-04       Impact factor: 8.317

10.  IgG and IgM autoantibody differences in discoid and systemic lupus patients.

Authors:  Benjamin F Chong; Lin-chiang Tseng; Thomas Lee; Rebecca Vasquez; Quan Z Li; Song Zhang; David R Karp; Nancy J Olsen; Chandra Mohan
Journal:  J Invest Dermatol       Date:  2012-07-05       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.